Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

29 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Growth hormone receptor variants and response to pegvisomant in monotherapy or in combination with somatostatin analogs in acromegalic patients: a multicenter study.
Filopanti M, Olgiati L, Mantovani G, Corbetta S, Arosio M, Gasco V, De Marinis L, Martini C, Bogazzi F, Cannavò S, Colao A, Ferone D, Arnaldi G, Pigliaru F, Peri A, Angeletti G, Jaffrain-Rea ML, Lania AG, Spada A. Filopanti M, et al. Among authors: olgiati l. J Clin Endocrinol Metab. 2012 Feb;97(2):E165-72. doi: 10.1210/jc.2011-1769. Epub 2011 Dec 7. J Clin Endocrinol Metab. 2012. PMID: 22162472 Clinical Trial.
The dopamine-somatostatin chimeric compound BIM-23A760 exerts antiproliferative and cytotoxic effects in human non-functioning pituitary tumors by activating ERK1/2 and p38 pathways.
Peverelli E, Olgiati L, Locatelli M, Magni P, Fustini MF, Frank G, Mantovani G, Beck-Peccoz P, Spada A, Lania A. Peverelli E, et al. Among authors: olgiati l. Cancer Lett. 2010 Feb 28;288(2):170-6. doi: 10.1016/j.canlet.2009.06.034. Epub 2009 Jul 19. Cancer Lett. 2010. PMID: 19619936
d3-Growth hormone receptor polymorphism in acromegaly: effects on metabolic phenotype.
Montefusco L, Filopanti M, Ronchi CL, Olgiati L, La-Porta C, Losa M, Epaminonda P, Coletti F, Beck-Peccoz P, Spada A, Lania AG, Arosio M. Montefusco L, et al. Among authors: olgiati l. Clin Endocrinol (Oxf). 2010 May;72(5):661-7. doi: 10.1111/j.1365-2265.2009.03703.x. Clin Endocrinol (Oxf). 2010. PMID: 20447065
Influence of the d3GH receptor polymorphism on the metabolic and biochemical phenotype of GH-deficient adults at baseline and during short- and long-term recombinant human GH replacement therapy.
Giavoli C, Ferrante E, Profka E, Olgiati L, Bergamaschi S, Ronchi CL, Verrua E, Filopanti M, Passeri E, Montefusco L, Lania AG, Corbetta S, Arosio M, Ambrosi B, Spada A, Beck-Peccoz P. Giavoli C, et al. Among authors: olgiati l. Eur J Endocrinol. 2010 Sep;163(3):361-8. doi: 10.1530/EJE-10-0317. Epub 2010 Jun 30. Eur J Endocrinol. 2010. PMID: 20592127
Role of glucocorticoid receptor polymorphism in adrenal incidentalomas.
Morelli V, Donadio F, Eller-Vainicher C, Cirello V, Olgiati L, Savoca C, Cairoli E, Salcuni AS, Beck-Peccoz P, Chiodini I. Morelli V, et al. Among authors: olgiati l. Eur J Clin Invest. 2010 Sep;40(9):803-11. doi: 10.1111/j.1365-2362.2010.02330.x. Epub 2010 Jun 23. Eur J Clin Invest. 2010. PMID: 20584071
29 results